AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 23212610
Drug: Oxycodone (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone (15 mg, oral)
Trial: 17354119
Drug: Morphine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (30 mg, oral)
Trial: 12084605
Drug: Omapatrilat 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omapatrilat 2.5 mg
Trial: 14751650
Drug: Omapatrilat 10
RxNorm normalized name: OMAPATRILAT
DrugBank: Omapatrilat (DB00886)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omapatrilat 10 mg
Trial: 12084605
Drug: Control (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (2.5 mg)
Trial: 9470006
Drug: Milk preparation
RxNorm normalized name: human milk preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk preparation (skimmed milk enriched with oleic acid)
Trial: 2650517
Drug: Intravenous diltiazem
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous diltiazem (0.25 mg/kg/2 minutes followed by 0.35 mg/kg/2 minutes if needed)
Trial: 2650517
Drug: Intravenous diltiazem
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous diltiazem after placebo
Trial: 31539075
Drug: Antiangiogenic agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiangiogenic agents
Trial: 31539075
Drug: Anti-epidermal growth
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-epidermal growth factor receptor agents
Trial: 12230317
Drug: Phytochemicals (plant-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phytochemicals (plant-based compounds)
Trial: 8522641
Drug: Single 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single 50 mg, 100 mg, and 200 mg oral doses of nefazodone hydrochloride
Trial: 8522641
Drug: Twice daily
RxNorm normalized name: CAPSULE, TWICE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice daily doses of 50 mg, 100 mg, and 200 mg of nefazodone hydrochloride for 7.5 days
Trial: 28452101
Drug: Combined low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Combined low-dose spironolactone plus vitamin E
Trial: 28452101
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E monotherapy
Trial: 25824210
Drug: Posaconazole 300
RxNorm normalized name: posaconazole 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Posaconazole 300 mg in tablet form with a high-fat meal
Trial: 25824210
Drug: Posaconazole 300
RxNorm normalized name: posaconazole 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Posaconazole 300 mg in tablet form in fasted state
Trial: 25824210
Drug: Posaconazole oral
RxNorm normalized name: posaconazole Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Posaconazole oral suspension with a high-fat meal
Trial: 23720786
Drug: GH treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH treatment (0.05 mg/kg recombinant human GH daily)
Trial: 18072840
Drug: Intensive smoking
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive smoking cessation intervention (three 1-hr counseling sessions plus 8 weeks of nicotine patch therapy)
Trial: 16294458
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg 17beta‐E2/0.25 mg TMG
Trial: 16353319
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg 17beta‐E2/0.125 mg TMG
Trial: 16294458
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg E2V/1 mg NET
Trial: 12478329
Drug: Telithromycin 800
RxNorm normalized name: Telithromycin
DrugBank: Telithromycin (DB00976)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Telithromycin 800 mg once daily
Trial: 12478329
Drug: Amoxicillin 1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin 1,000 mg three times a day
Trial: 12478329
Drug: Amoxicillin (subset
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin (subset analysis)
Trial: 9890248
Drug: Nonteratogenic antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonteratogenic antibiotics (Control)
Trial: 2478340
Drug: 53.3 g
RxNorm normalized name: ALCOHOL 53.3 g in 100 mL TOPICAL LIQUID [Hand Sanitizer]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 53.3 g albumin as part of blood replacement therapy, followed by 20 g albumin daily for the first three postoperative days
Trial: 29135370
Drug: Adjusted dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjusted dose of Ribavirin (ADJ)
Trial: 29135370
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose of Ribavirin (STD)
Trial: 28601497
Drug: Daily oral
RxNorm normalized name: GEMTESA 75 MG Once-Daily Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily oral antipsychotics
Trial: 20115934
Drug: Standard antidiabetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard antidiabetic treatment
Trial: 14760265
Drug: Milk-specific IgE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk-specific IgE <2 kU/L
Trial: 14760265
Drug: Milk-specific IgE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk-specific IgE >=2 kU/L
Trial: 7970937
Drug: Corticotropin-releasing hormone
RxNorm normalized name: corticotropin-releasing hormone
DrugBank: Corticorelin (DB05394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticotropin-releasing hormone (CRH) administration (1 microgram/kg i.v. bolus)
Trial: 7970937
Drug: Corticotropin-releasing hormone
RxNorm normalized name: corticotropin-releasing hormone
DrugBank: Corticorelin (DB05394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticotropin-releasing hormone (CRH) administration
Trial: 7970937
Drug: Metyrapone administration
RxNorm normalized name: Metyrapone
DrugBank: Metyrapone (DB01011)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metyrapone administration (450 mg/m2/dose every 4 h x seven doses)
Trial: 12843168
Drug: Metyrapone administration
RxNorm normalized name: Metyrapone
DrugBank: Metyrapone (DB01011)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metyrapone administration
Trial: 3301758
Drug: Misonidazole (2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Misonidazole (2.0 gm/m2/wk X 6 doses) with altered fractionation (2.5 Gy in a.m., 2.1 Gy in p.m.)
Trial: 3301758
Drug: Misonidazole (2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Misonidazole (2.0 gm/m2/wk X 6 doses)
Trial: 28701205
Drug: Art therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Art therapy
Trial: 30313053
Drug: Esmolol (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esmolol (0.5 mg/kg bolus followed by infusion of 5 to 15 μg/kg/min)
Trial: 20923446
Drug: Topical Aloe
RxNorm normalized name: Alo Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical Aloe vera (AV) 0.4 ml (70% concentration) three times a day
Trial: 20923446
Drug: Topical Aloe
RxNorm normalized name: Alo Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical Aloe vera (AV)
Trial: 17260222
Drug: Regime B:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regime B: loading dose of 600 microg, followed by 200 microg every 3 h
Trial: 14659328
Drug: epirubicin/vinorelbine and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: epirubicin/vinorelbine and sequential paclitaxel (EV/T)
Trial: 14659328
Drug: epirubicin/cyclophosphamide plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: epirubicin/cyclophosphamide plus sequential paclitaxel (EC/T)
Trial: 8829944
Drug: Epidural analgesia
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural analgesia with diamorphine (2 mg initial dose, 0.2 mg h-1 background infusion, 0.2 mg on-demand doses with a 15 min lockout)
Trial: 29497279
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg eletriptan HBr
Trial: 29497279
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg eletriptan HBr
Trial: 29497279
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg eletriptan HBr
Trial: 29497279
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg eletriptan HBr (repeated oral dose 2 h apart)
Trial: 24281285
Drug: Manual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual therapy protocol (5 sessions)
Trial: 24281285
Drug: Manual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual therapy protocol
Trial: 22571284
Drug: Total knee
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total knee arthroplasty (TKA) in addition to optimised non-surgical treatment
Trial: 22571284
Drug: Optimised non-surgical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimised non-surgical treatment alone
Trial: 19248130
Drug: Step-up combination
RxNorm normalized name: PostDay One-Step
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Step-up combination therapy
Trial: 20472597
Drug: Initial combination
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initial combination with prednisone
Trial: 20472597
Drug: Initial combination
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initial combination with infliximab
Trial: 10374215
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogens 0.625 mg/day with norgestrel 0.15 mg/day
Trial: 7065478
Drug: Oral terbutaline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral terbutaline (2.5-5.0 mg)
Trial: 30816637
Drug: Sorafenib 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sorafenib 400 mg by mouth daily
Trial: 25837634
Drug: G‐eCPD module
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G‐eCPD module (n = 80)
Trial: 19476985
Drug: Low-dose, slow-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose, slow-release transdermal glyceryl trinitrate (GTN) patch
Trial: 19476985
Drug: Matched control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Matched control group (no immediate treatment for PSA recurrence)
Trial: 19476985
Drug: Treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment group (GTN)
Trial: 14993623
Drug: Sulfadoxine/pyrimethamine (SP)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfadoxine/pyrimethamine (SP) - 25 mg/kg of sulfadoxine and 1.25 mg/kg of pyrimethamine
Trial: 14993623
Drug: Chloroquine (CQ)
RxNorm normalized name: Chloroquine
DrugBank: Chloroquine (DB00608)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chloroquine (CQ) - 25 mg/kg
Trial: 15570192
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose (10 mg) methamphetamine hydrochloride
Trial: 15570192
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose (20 mg) methamphetamine hydrochloride
Trial: 15570192
Drug: Both doses
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both doses (10 mg and 20 mg)
Trial: 7572649
Drug: Intravenous dipyridamole
RxNorm normalized name: Dipyridamole
DrugBank: Dipyridamole (DB00975)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous dipyridamole (0.7 to 0.8 mg/kg) stress testing (Dip)
Trial: 7572649
Drug: Dipyridamole (0.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyridamole (0.7 to 0.8 mg/kg) plus nonlimited exercise stress testing (Dip+Ex)
Trial: 7572649
Drug: Dipyridamole (0.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyridamole (0.7 to 0.8 mg/kg) stress testing (Dip)
Trial: 2149285
Drug: Toremifene 240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Toremifene 240 mg daily
Trial: 2149285
Drug: Toremifene 60
RxNorm normalized name: toremifene 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Toremifene 60 mg daily
Trial: 2149285
Drug: Tamoxifen 20-40
RxNorm normalized name: tamoxifen 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen 20-40 mg daily
Trial: 7015988
Drug: sotalol (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sotalol (80 mg b.i.d.)
Trial: 7015988
Drug: atenolol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: atenolol (50 mg b.i.d.)
Trial: 7015988
Drug: sotalol +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sotalol + prazosin (3-5 mg b.i.d.)
Trial: 7015988
Drug: atenolol +
RxNorm normalized name: Atenolol
DrugBank: Atenolol (DB00335)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: atenolol + prazosin (3-5 mg b.i.d.)
Trial: 7015988
Drug: prazosin (3-5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: prazosin (3-5 mg b.i.d.) alone
Trial: 20648212
Drug: Lumbar interlaminar
RxNorm normalized name: camphor
DrugBank: Camphor (DB01744)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lumbar interlaminar epidural injections
Trial: 17296625
Drug: ICD therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICD therapy for ventricular tachyarrhythmias
Trial: 7654893
Drug: SCFA treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCFA treatment (100 mL, twice daily enemas of sodium acetate 80 mmol/L, sodium propionate 30 mmol/L and sodium butyrate 40 mmol/L)
Trial: 7654893
Drug: SCFA treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCFA treatment
Trial: 29223437
Drug: Heparin with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin with or without GPI
Trial: 15870629
Drug: NaHCO3 ingestion
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NaHCO3 ingestion (0.2 g x kg(‐1))
Trial: 15870629
Drug: NaCl (placebo,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NaCl (placebo, 0.138 g x kg(‐1))
Trial: 12049015
Drug: Epidural Ropivacain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural Ropivacain (R) infusion
Trial: 12049015
Drug: Epidural Bupivacain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural Bupivacain (B) infusion
Trial: 10613613
Drug: Dextromethorphan (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextromethorphan (80 mg)
Trial: 10613613
Drug: Chloroguanide (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloroguanide (200 mg)
Trial: 7778068
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg subcutaneous
Trial: 7778068
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg subcutaneous
Trial: 7778068
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg intravenous
Trial: 6999545
Drug: Naproxen tablets
RxNorm normalized name: Naproxen Tablets
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naproxen tablets
Trial: 356764
Drug: Naproxen suppositories
RxNorm normalized name: naproxen Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen suppositories
Trial: 21375606
Drug: Five-grass pollen
RxNorm normalized name: grass pollen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Five-grass pollen sublingual immunotherapy tablets
Trial: 17709354
Drug: Group A
RxNorm normalized name: Blood group A IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A received routine postoperative advice and a three-day prescription of paracetamol, ibuprofen, and codeine.
Trial: 11979408
Drug: Complicated appendicitis
RxNorm normalized name: AVOBENZONE 3 g in 100 g / HOMOSALATE 10 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 10 g in 100 g / OXYBENZONE 5 g in 100 g TOPICAL AEROSOL, SPRAY [UNCOMPLIKATED MAKEUP SETTING SPF 50]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complicated appendicitis treatment
Trial: 8109489
Drug: Corticosteroid pretreatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid pretreatment (32-mg oral dose of methylprednisolone administered 6-24 hr before and again 2 hr before injection)
Trial: 8109489
Drug: Placebo (administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (administered in the same time periods)
Trial: 1095631
Drug: Papaverine hydrochloride
RxNorm normalized name: Papaverine Hydrochloride
DrugBank: Papaverine (DB01113)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Papaverine hydrochloride (300 mg)
Trial: 29016336
Drug: Mebendazole (MBZ)
RxNorm normalized name: Mebendazole
DrugBank: Mebendazole (DB00643)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mebendazole (MBZ) 500 mg chewable tablet
Trial: 21816977
Drug: Intensive multifactorial
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive multifactorial treatment (IT)
Trial: 24377409
Drug: Psychoanalytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychoanalytic therapy (average of 97 sessions, range: 25-205)
Trial: 24377409
Drug: Wait-list control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wait-list control group (minimal treatment)
Trial: 19568355
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg triamcinolone acetonide
Trial: 19568355
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg triamcinolone acetonide
Trial: 19568355
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg triamcinolone acetonide
Trial: 15755868
Drug: HRT-EVP (sequential
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HRT-EVP (sequential estradiol valerate plus progestin)
Trial: 10656038
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg oral penicillin
Trial: 10656038
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg DEC/kg
Trial: 10656038
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg oral penicillin plus 1 mg DEC/kg
Trial: 10656038
Drug: local antibiotics
RxNorm normalized name: RECTAL,LOCAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: local antibiotics
Trial: 8521712
Drug: Continuous levonorgestrel
RxNorm normalized name: Levonorgestrel
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Continuous levonorgestrel treatment with subdermal implants (Norplant)
Trial: 2245269
Drug: Treatment during
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment during the Sheffield Psychotherapy Project
Trial: 2245269
Drug: Exploratory therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exploratory therapies
Trial: 17122090
Drug: Oral micronized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral micronized progesterone (100 mg)
Trial: 27356530
Drug: Dutasteride 0.5
RxNorm normalized name: dutasteride 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dutasteride 0.5 mg soft gelatin capsule (marketed formulation)
Trial: 27356530
Drug: Dutasteride 0.5
RxNorm normalized name: dutasteride 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dutasteride 0.5 mg hard gelatin capsule
Trial: 27356530
Drug: Dutasteride 0.5
RxNorm normalized name: dutasteride 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dutasteride 0.5 mg soft gelatin capsules with 300 mg MDC8
Trial: 27356530
Drug: Dutasteride 0.5
RxNorm normalized name: dutasteride 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dutasteride 0.5 mg soft gelatin capsules with 100 mg MDC8
Trial: 20092962
Drug: Concurrent chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent chemotherapy and radiotherapy (CRT)
Trial: 15837357
Drug: Oral chloramphenicol
RxNorm normalized name: Chloramphenicol
DrugBank: Chloramphenicol succinate (DB07565)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral chloramphenicol (50mg/kg/day in four divided doses for 14 days)
Trial: 15837357
Drug: Ofloxacin (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ofloxacin (15 mg/kg/day in two divided doses for 3 days)
Trial: 12028688
Drug: Dipyridamole (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyridamole (750 mg)
Trial: 1918724
Drug: Budesonide (BUD)
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide (BUD) 1.2 mg per day
Trial: 1918724
Drug: Budesonide (BUD)
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide (BUD) 2.4 mg per day
Trial: 1918724
Drug: Morning dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morning dosing schedule
Trial: 22093134
Drug: Valganciclovir (VGV)
DrugBank: Valganciclovir (DB01610)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Valganciclovir (VGV) 900 mg b.i.d. for 7 days followed by 900 mg daily for up to 21 days
Trial: 22093134
Drug: Ganciclovir (GCV)
RxNorm normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ganciclovir (GCV) 5 mg/kg b.i.d. for 7 days followed by daily GCV 5 mg/kg for up to 21 days